MedTrace Logo

Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus

NCT07237685 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-11-20

No results posted yet for this study

Summary

People with type 2 diabetes have a much higher risk of heart disease. One common problem is when the blood vessels that supply the heart become narrowed or blocked by fatty deposits, called plaque. This makes it harder for blood to reach the heart and can lead to serious problems such as chest pain, heart attacks, or even death.

This study will follow people with type 2 diabetes who have already had a special heart scan called a coronary CT angiography. This scan takes detailed pictures of the heart's blood vessels.

The goal is to understand how heart disease changes over time in people with type 2 diabetes, by looking at repeat scans and other health information. By learning more about how plaque builds up or gets worse, researchers hope to find better ways to identify which patients are most at risk for future heart problems.

Conditions

  • Type 2 Diabetes
  • Coronary Artery Disease (CAD)
  • Atherosclerosis Cardiovascular Disease

Sponsors & Collaborators

  • Horizon Innovative Health Initiative

    collaborator UNKNOWN

  • Novo Nordisk A/S

    collaborator INDUSTRY

  • INSTITUTO DE INVESTIGACION BIOMEDICA DE SALAMANCA (IBSAL)

    collaborator UNKNOWN

  • Cardiology Centers of the Netherlands

    collaborator UNKNOWN

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-06
Primary Completion
2026-10-01
Completion
2036-10-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07237685 on ClinicalTrials.gov